Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingwen Twelve-Flavor Pills is a Traditional Mongolian Medicine (TMM) formulation traditionally used to treat infectious diseases characterized by "myxosis" acute fever. The preparation consists of twelve herbal and mineral ingredients, including *Piper longum* L., *Terminalia chebula* Retz., and *Phyllanthus emblica* L. It is primarily indicated for clearing heat, detoxification, and treating lung infections. During the COVID-19 pandemic, it was evaluated in clinical trials in China for its potential to improve clinical symptoms, reduce viral load, and manage lung inflammation in patients with coronavirus disease 2019. The formula is developed and utilized by institutions such as the Affiliated Hospital of Inner Mongolia University for the Nationalities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingwen Twelve-Flavor Pills.